Jazz Pharmaceuticals PLC to Acquire GW Pharmaceuticals PLC Call Transcript
Welcome to Jazz Pharmaceuticals Investor Update Conference Call. (Operator Instructions) I will now turn the call over to Andrea Flynn, Vice President and Head of Investor Relations at Jazz Pharmaceuticals.
Thank you, and good morning, everyone. Thanks for joining our call today to discuss Jazz's acquisition of GW Pharmaceuticals. Joining me today are Bruce Cozadd, our Co-Founder, Chairman and CEO; Renée Galá, our CFO; and Justin Gover, CEO of GW Pharmaceuticals. Jazz's President, Dan Swisher and Executive Vice President of R&D, Rob Iannone as well as GW's CFO, Scott Giacobello, will join for Q&A.
As a reminder, this call is being recorded and a press release and slide presentation regarding today's news are available on the Investor Relations section of Jazz and GW's respective website. This communication is not intended to constitute an offer to buy or sell or the solicitation of an offer to buy any securities, or solicitation of any vote or approval. GW intends to file a proxy statement with the SEC regarding the proposed transaction
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |